Tuesday Plenary

AUTM Annual Meeting

Plenary: VC’s Talk Back – The State of Early-Stage Science-based Venture Capital

Tuesday, March 10
10:30 a.m. – Noon

Senior leadership from prominent VC firms will join moderator Orin Herskowitz, from Columbia Tech Ventures, to discuss the complex intersection of venture capital and university tech transfer. This interactive, audience-driven session will cover current investment hypotheses and emerging best practices for forging deeper ties between VCs and universities.

Kevin Bitterman, Atlas Venture
Bill Harrington, Osage University Partners
Deborah Palestrant, 4:59
Cami Samuels, Venrock
Amy Schulman, Polaris Partners
Jeff Tong, Third Rock Ventures

Orin Herskowitz is the Senior VP of Intellectual Property and Tech Transfer for Columbia University, as well as Executive Director of Columbia Technology Ventures (CTV). He is an Adjunct Professor at Columbia teaching IP for Entrepreneurs and has been peer reviewer for NSF and APLU grants. He serves on the Boards of the Center for American Entrepreneurship; the IBM Columbia Blockchain Center; the NYC Media Lab; the NYC AR VR Lab; and other organizations. He is a principal investigator for multiple innovation and entrepreneurship grants, such as PowerBridgeNY and CyberNYC and a former member of the National Advisory Committee on Innovation and Entrepreneurship (NACIE) for the Secretary of Commerce.

Annual Meeting Sponsors

Elanco Animal Health
Osage University Partners
Amster, Rothstein & Ebenstein LLP
Burford Capital
Parker Highlander PLLC
Boehringer Ingelheim Pharmaceuticals Inc.
Marshall Gerstein
Michael Best & Friedrich
Bereskin & Parr LLP
Novartis Institutes for BioMedical Research
Hamilton Brook Smith Reynolds
Eli Lilly and Company
BCC Research
Schwegman Lundberg & Woessner
Blank Rome LLP
Baker Donelson
Casimir Jones, SC
Royalty Pharma
Smith, Gambrell & Russell
Pabst Patent Group LLP
Quarles & Brady LLP
Hodgson Russ LLP
TreMonti Consulting LLC